IP Library Granted Patent US 10,029,985
Granted Patent B2
US 10,029,985 · App. 15/829,344 · Granted Jul 24, 2018

Methods of preparing Tecovirimat

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,029,985
App. No.
15/829,344
Granted
Jul 24, 2018
Kind
B2
Abstract

Disclosed are methods for the preparation of Tecovirimat for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the orthopoxvirus.

Claims (14)

1. A method for producing N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide, said method comprising:

(a) reacting maleic anhydride (compound 2) and tert-butyl carbazate (compound 5) to form compound 10 of formula:

(b) reacting compound 10 with an acid to form compound 11 or salt thereof of formula:

(c) reacting compound 11 with 4-(trifluoromethyl)benzoyl halide (compound 8) to form compound 9 of formula:

(d) reacting compound 9 with cycloheptatriene (compound 1); and

(e) collecting N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide.

2. The method of claim 1 , wherein step (a) is carried out in anhydrous toluene under nitrogen atmosphere and reactants heated to reflux.

3. The method of claim 1 , wherein said acid in step (b) is HCl.

4. The method of claim 1 , wherein compound 10 is dissolved in i-PrOAc prior to the reaction of step (b).

5. The method of claim 1 , wherein a base is present in the reaction of step (c), wherein said base is selected from the group consisting of: pyridine, 4-dimethylaminopyridine, triethylamine and diisopropylethylamine.

6. The method of claim 1 , wherein said 4-(trifluoromethyl)benzoyl halide is 4-(trifluoromethyl)benzoyl chloride.

7. The method of claim 1 , wherein step (c) is carried out at a temperature of about 10 to about 25° C.

8. The method of claim 1 , wherein step (d) is carried out in toluene under nitrogen atmosphere at a temperature above about 110° C.

9. The method of claim 1 , wherein said N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)-benzamide collected in step (e) is further purified by column chromatography.

Assignments (2)
CHANGE OF ADDRESS Recorded Mar 25, 2026
From: SIGA TECHNOLOGIES, INC.
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 075242/0438 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2017
From: DAI, DONGCHENG
To: SIGA TECHNOLOGIES, INC.,
Reel/Frame 044276/0951 →